Cargando…
The emergence and diffusion of DNA microarray technology
The network model of innovation widely adopted among researchers in the economics of science and technology posits relatively porous boundaries between firms and academic research programs and a bi-directional flow of inventions, personnel, and tacit knowledge between sites of university and industr...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590052/ https://www.ncbi.nlm.nih.gov/pubmed/16925816 http://dx.doi.org/10.1186/1747-5333-1-11 |
_version_ | 1782130367695683584 |
---|---|
author | Lenoir, Tim Giannella, Eric |
author_facet | Lenoir, Tim Giannella, Eric |
author_sort | Lenoir, Tim |
collection | PubMed |
description | The network model of innovation widely adopted among researchers in the economics of science and technology posits relatively porous boundaries between firms and academic research programs and a bi-directional flow of inventions, personnel, and tacit knowledge between sites of university and industry innovation. Moreover, the model suggests that these bi-directional flows should be considered as mutual stimulation of research and invention in both industry and academe, operating as a positive feedback loop. One side of this bi-directional flow – namely; the flow of inventions into industry through the licensing of university-based technologies – has been well studied; but the reverse phenomenon of the stimulation of university research through the absorption of new directions emanating from industry has yet to be investigated in much detail. We discuss the role of federal funding of academic research in the microarray field, and the multiple pathways through which federally supported development of commercial microarray technologies have transformed core academic research fields. Our study confirms the picture put forward by several scholars that the open character of networked economies is what makes them truly innovative. In an open system innovations emerge from the network. The emergence and diffusion of microarray technologies we have traced here provides an excellent example of an open system of innovation in action. Whether they originated in a startup company environment that operated like a think-tank, such as Affymax, the research labs of a large firm, such as Agilent, or within a research university, the inventors we have followed drew heavily on knowledge resources from all parts of the network in bringing microarray platforms to light. Federal funding for high-tech startups and new industrial development was important at several phases in the early history of microarrays, and federal funding of academic researchers using microarrays was fundamental to transforming the research agendas of several fields within academe. The typical story told about the role of federal funding emphasizes the spillovers from federally funded academic research to industry. Our study shows that the knowledge spillovers worked both ways, with federal funding of non-university research providing the impetus for reshaping the research agendas of several academic fields. |
format | Text |
id | pubmed-1590052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15900522006-10-05 The emergence and diffusion of DNA microarray technology Lenoir, Tim Giannella, Eric J Biomed Discov Collab Case Study The network model of innovation widely adopted among researchers in the economics of science and technology posits relatively porous boundaries between firms and academic research programs and a bi-directional flow of inventions, personnel, and tacit knowledge between sites of university and industry innovation. Moreover, the model suggests that these bi-directional flows should be considered as mutual stimulation of research and invention in both industry and academe, operating as a positive feedback loop. One side of this bi-directional flow – namely; the flow of inventions into industry through the licensing of university-based technologies – has been well studied; but the reverse phenomenon of the stimulation of university research through the absorption of new directions emanating from industry has yet to be investigated in much detail. We discuss the role of federal funding of academic research in the microarray field, and the multiple pathways through which federally supported development of commercial microarray technologies have transformed core academic research fields. Our study confirms the picture put forward by several scholars that the open character of networked economies is what makes them truly innovative. In an open system innovations emerge from the network. The emergence and diffusion of microarray technologies we have traced here provides an excellent example of an open system of innovation in action. Whether they originated in a startup company environment that operated like a think-tank, such as Affymax, the research labs of a large firm, such as Agilent, or within a research university, the inventors we have followed drew heavily on knowledge resources from all parts of the network in bringing microarray platforms to light. Federal funding for high-tech startups and new industrial development was important at several phases in the early history of microarrays, and federal funding of academic researchers using microarrays was fundamental to transforming the research agendas of several fields within academe. The typical story told about the role of federal funding emphasizes the spillovers from federally funded academic research to industry. Our study shows that the knowledge spillovers worked both ways, with federal funding of non-university research providing the impetus for reshaping the research agendas of several academic fields. BioMed Central 2006-08-22 /pmc/articles/PMC1590052/ /pubmed/16925816 http://dx.doi.org/10.1186/1747-5333-1-11 Text en Copyright © 2006 Lenoir and Giannella; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Study Lenoir, Tim Giannella, Eric The emergence and diffusion of DNA microarray technology |
title | The emergence and diffusion of DNA microarray technology |
title_full | The emergence and diffusion of DNA microarray technology |
title_fullStr | The emergence and diffusion of DNA microarray technology |
title_full_unstemmed | The emergence and diffusion of DNA microarray technology |
title_short | The emergence and diffusion of DNA microarray technology |
title_sort | emergence and diffusion of dna microarray technology |
topic | Case Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590052/ https://www.ncbi.nlm.nih.gov/pubmed/16925816 http://dx.doi.org/10.1186/1747-5333-1-11 |
work_keys_str_mv | AT lenoirtim theemergenceanddiffusionofdnamicroarraytechnology AT giannellaeric theemergenceanddiffusionofdnamicroarraytechnology AT lenoirtim emergenceanddiffusionofdnamicroarraytechnology AT giannellaeric emergenceanddiffusionofdnamicroarraytechnology |